Explore the complete record of transactions filed by 강성용, Director. Officer active across 1 company, notably 화일약품. Cumulatively, 17,943 disclosures have been recorded. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is free.
Kang Seong-yong is a Board Member at Hwa-il Pharmaceutical, where he contributes to the governance and strategic direction of the company. His role involves providing counsel and overseeing the company's activities to ensure compliance and efficiency. Kang Seong-yong is valued for his expertise and vision in the sector.